Labeling: Label Error on Declared Strength: Incorrect strength on side display panel of label
Labeling: Label Error on Declared Strength: Incorrect strength on side display panel of label
We break every recall down into plain English — this one’s still on our list. Until our write-up is ready, the official FDA hazard and remedy below have the full, accurate details.
We’ve drafted a message you can send Aurobindo Pharma USA Inc to request your refund or repair — edit it as you like.
Subject: Recall D-498-2013 — Aurobindo Pharma USA Inc Aurobindo Pharma USA Inc recalls Lisinopril Tablets, USP, 30 mg, Rx only, 1 Hello, I own a Aurobindo Pharma USA Inc recalls Lisinopril Tablets, USP, 30 mg, Rx only, 100 tablets, NDC 65862-041-01 Manufactured for: Aurobindo Pharma USA Inc. 2400 that is covered by recall D-498-2013 from Aurobindo Pharma USA Inc. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
